Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wattanapat Hospital Trang PCLBKK:WPH-R -3.72%81 EV-to-EBIT is 12.60 as of Aug. 26, 2026, which is 40% below its 10-year median of 21.10. GuruFocus rates BKK:WPH-R with a GF Score™ of 81/100 and a GF Value™ of ฿9.50 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 479 Healthcare Providers & Services companies, Wattanapat Hospital Trang PCL ranks better than 61.8% on this metric.
The historical rank and industry rank for Wattanapat Hospital Trang PCL's EV-to-EBIT or its related term are showing as below:
BKK:WPH-R'
s EV-to-EBIT Range Over the Past 10 Years
Min: -250.24 Med: 21.1 Max: 654.51
Current: 12.6
During the past 12 years, the highest EV-to-EBIT of Wattanapat Hospital Trang PCL was 654.51. The lowest was -250.24. And the median was 21.10.
BKK:WPH-R's EV-to-EBIT is ranked better than 61.8% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 15.7
vs BKK:WPH-R: 12.60
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Wattanapat Hospital Trang PCL's Enterprise Value for the quarter that ended in Jun. 2026 was ฿5,605 Mil.
Wattanapat Hospital Trang PCL's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿435 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wattanapat Hospital Trang PCL EV-to-EBIT Related Terms
Wattanapat Hospital Trang PCL EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Wattanapat Hospital Trang PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wattanapat Hospital Trang PCL EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wattanapat Hospital Trang PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Wattanapat Hospital Trang PCL's EV-to-EBIT falls into.
Wattanapat Hospital Trang PCL's current Enterprise Value is ฿5,482 Mil.
Wattanapat Hospital Trang PCL's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿435 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wattanapat Hospital Trang PCL (BKK:WPH-R) has a EV-to-EBIT of 12.60 as of Aug. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Wattanapat Hospital Trang PCL and its competitors. This is 40% below median its historical median of 21.10. According to the industry distribution chart, Wattanapat Hospital Trang PCL ranks #183 out of 479 companies in the Healthcare Providers & Services industry, placing it in the top 38.2%.
Is Wattanapat Hospital Trang PCL's EV-to-EBIT too high?
Wattanapat Hospital Trang PCL's current EV-to-EBIT of 12.60 is 40% below median its 10-year median of 21.10. The Healthcare Providers & Services industry median EV-to-EBIT is 15.70. Wattanapat Hospital Trang PCL's value of 12.60 is 19.7% below this industry median. Based on the distribution chart, Wattanapat Hospital Trang PCL ranks #183 out of 479 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Wattanapat Hospital Trang PCL has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wattanapat Hospital Trang PCL's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattanapat Hospital Trang PCL ranks #183 out of 479 companies for EV-to-EBIT. This puts Wattanapat Hospital Trang PCL in the upper half of its industry. The industry median EV-to-EBIT is 15.70. Wattanapat Hospital Trang PCL's value of 12.60 is 19.7% below this benchmark. While the company's 10-year median is 21.10 vs. the industry median of 15.70, Wattanapat Hospital Trang PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.70, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wattanapat Hospital Trang PCL's current EV-to-EBIT of 12.60 is 19.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Wattanapat Hospital Trang PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattanapat Hospital Trang PCL's current EV-to-EBIT is 12.60, which is 40% below median its own 10-year median of 21.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattanapat Hospital Trang PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattanapat Hospital Trang PCL (BKK:WPH-R) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿9.50, compared to a current price of ฿5.75 — trading 39.5% below its estimated fair value. The current EV-to-EBIT is 12.60, which is 40% below median its 10-year median of 21.10 and 19.7% below the Healthcare Providers & Services industry median of 15.70. Wattanapat Hospital Trang PCL's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Wattanapat Hospital Trang PCL (BKK:WPH-R), the current EV-to-EBIT is 12.60 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wattanapat Hospital Trang PCL (BKK:WPH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Wattanapat Hospital Trang PCL stock appears to be undervalued.
The current stock price of ฿5.75 is trading 39.5% below its estimated GF Value™ of ฿9.50.
GuruFocus considers Wattanapat Hospital Trang PCL to be Significantly Undervalued.
Key valuation signals for BKK:WPH-R:
EV-to-EBIT: 12.60 (40% below median its 10-year median of 21.10)
GF Value™: ฿9.50 vs. price of ฿5.75 (39.5% below fair value)
Industry Position: 19.7% below the Healthcare Providers & Services median (#183 of 479)
No single metric tells the full story. See the BKK:WPH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wattanapat Hospital Trang PCL Ltd is engaged in medical services. Its operations are carried on only in Thailand. The company offers a range of services including Orthopedic Clinic, Neurosurgery Clinic, Neurology and Brain Clinic, Surgical Clinic, Heart Clinic, Internal Medicine Clinic, Obstetrics and Gynecology Clinic, Gastrointestinal and Liver Clinic, Children's Clinic, Eye Clinic, ENT Clinic, Dental Clinic, Dermatology and Beauty Clinic, Health Promotion Center, Other Centers and Clinics.
81GF Score
Get the complete analysis for BKK:WPH-R
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:WPH-R has been successfully added to your 
